Evexia Lifecare shares surged on Tuesday. The company, which shifted its focus to pharmaceutical chemical trading in 2020, reported robust Q1FY26 results. Net sales increased by 4% to ₹22.09 crore, and net profit dramatically rose by 163% to ₹0.63 crore compared to Q1FY25. Evexia Lifecare has a market cap exceeding ₹400 crore.